Recently, several lines of evidence have proven that USP22 plays a major role in stem cell function. USP22 can be considered a cancer stem cell marker gene due to its activity, which facilitates aggressive cellular phenotypes, including metastatic potential and resistance to therapy [130, 131]. This evidence concerns the gene USP22 and cancer.